by John Conrad | May 6, 2024 | Member News
Xeris announced a collaboration and licensing agreement with Beta Bionics. The agreement involves developing and commercializing a glucagon product using Xeris’ XeriSol™ technology for Beta Bionics’ proprietary bi-hormonal pump system for diabetes...
by John Conrad | Aug 3, 2022 | iBIO in the News
llinois is recognized as a national leader in the life sciences industry, which employs more than 41,000 people across the state. A 2019 report found the overall economic output of the life sciences industry in Illinois was $98 billion, with pharmaceutical research...
by John Conrad | Mar 29, 2022 | iBIO in the News
The biosciences community in the Chicago area continues to experience tremendous growth, particularly during the last two years. In fact, the Illinois Biotechnology Innovation Organization’s (iBIO) most recent research report shows that Illinois is ranked in the top...
